We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Several cases of renal and testis along with rare skin, stomach, pancreatic cancers along with lymphoma and melanoma exhibited moderate cytoplasmic positivity. Rare cases of urothelial and lung cancers showed moderate cytoplasmic and nuclear positivity. Remaining cancers were weakly stained or negative.
GENE INFORMATION
Gene name
BLMH (HGNC Symbol)
Synonyms
BH
Description
Bleomycin hydrolase (HGNC Symbol)
Entrez gene summary
Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution; however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008]
Enzymes ENZYME proteins Hydrolases Peptidases Cysteine-type peptidases Predicted intracellular proteins Plasma proteins Cancer-related genes Candidate cancer biomarkers Protein evidence (Kim et al 2014) Protein evidence (Ezkurdia et al 2014)